Aims and objectives To investigate health‐related quality of life in a representative sample of
adults with diabetes mellitus in Spain, as well as its clinical and sociodemographic …

Basal-bolus therapy (BBT) refers to the combination of a long-acting basal insulin with a
rapid-acting insulin at mealtimes. Basal insulin glargine 100 U/mL and prandial insulin lispro …

In silico simulations have become essential for the development of diabetes treatments.
However, currently available simulators are not challenging enough and often suffer from …

Introduction. The increasing knowledge of adropin, afamin, and neudesin and the regulation
of glucose metabolism and insulin resistance allows for the assessment of the differences in …

Aim: To analyze the clinical effect of continuous subcutaneous insulin infusion (CSII) in type
1 diabetes mellitus (T1D) patients in the Spanish real-world scenario. Methods: All T1D …

Background: Continuous subcutaneous insulin infusion (CSII) treatment with a tubeless
patch pump has not been previously evaluated in a large cohort of patients. Methods: This …

Insulin therapy is the most effective way to control the blood glucose value of diabetic
patients. The most effective administration route for insulin is subcutaneous injection …

Objectives To evaluate the clinical and economic consequences of continuous
subcutaneous insulin infusion (CSII) vs. multiple daily injections (MDI) in children and …

Aims: To analyze prevalence and clinical effect of continuous subcutaneous insulin infusion
(CSII) in adult type 1 diabetes mellitus (T1DM) patients in a public health system real-world …

Aims To assess safety and benefits of continuous subcutaneous insulin infusion (CSII)
therapy in a cohort of type 1 diabetes patients in Spain. Methods A web-based national …